Atherosclerosis and cancer are chronic diseases considered two of the main causes of
death all over the world. Taking into account that both diseases are multifactorial, they share …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Heart attack and
stroke cause irreversible tissue damage. The currently available treatment options are …

Controlling nanocarrier interactions with the immune system requires a thorough
understanding of the surface properties that modulate protein adsorption in biological fluids …

Flash nanoprecipitation (FNP) has proven to be a powerful tool for the rapid and scalable
assembly of solid-core nanoparticles from block copolymers. The process can be performed …

Atherosclerosis, a leading cause of heart disease, results from chronic vascular
inflammation that is driven by diverse immune cell populations. Nanomaterials may function …

Chronic inflammatory microenvironment is the predominant milieu that promotes the
progression of atherosclerosis (AS). However, targeted regulation of the chronic …

In this work, the hydrophobic small molecule NF-κB inhibitor celastrol was loaded into poly
(ethylene glycol)-b-poly (propylene sulfide)(PEG-b-PPS) micelles. PEG-b-PPS micelles …

Nanocarrier administration has primarily been restricted to intermittent bolus injections with
limited available options for sustained delivery in vivo. Here, we demonstrate that cylinder-to …

Despite several recent advances, current therapy and prevention strategies for myocardial
infarction are far from satisfactory, owing to limitations in their applicability and treatment …

Self-assembled soft nanocarriers that are capable of simultaneous encapsulation of both
lipophilic and water soluble payloads have significantly enhanced controlled delivery …